PTH and plasma cell myeloma: Because MM mainly affects elderly people and MM bone disease seems to be a reflection of osteoblast deactivation resulting from myeloma cell secretion of Wnt inhibitors such as DKK1 [16], [33], we hypothesize that daily administered PTH will help control disease progression indirectly by stimulating bone formation.